Approximately 25 million Americans suffer from asthma—a chronic lung disease that inflames and narrows the airways.  Asthma has been on the rapid rise since the early 1980s.  Children are much more vulnerable to asthma than adults.  (Asthma affects nearly 10 percent of children compared to less than five percent of adults.)   In fact, asthma is the most prevalent chronic condition that affects children.

Asthma symptoms include:

  • Wheezing
  • Coughing
  • Chest tightness
  • Shortness of breath
  • Mucus in the lungs and airways

Allergy and Asthma:  A Link?

Most people who have asthma also suffer from allergies (roughly 60 to 80 percent).  Why the connection?  It all starts with a harmless allergen (pollen, pet dander, allergenic foods, etc.)  When the immune system of an allergic person encounters this allergen, it reacts by releasing chemicals (histamine) into the body.  These chemicals lead to swelling of the lungs and air passageways, lots of mucus production, etc.

Managing Asthma:

Asthma symptoms are commonly treated with inhaled corticosteroids.  Some patients find these to be effective, but they can have harmful side effects.

In cases where asthma is allergy-related, allergy immunotherapy may prove to be a more long-term solution to asthma because it addresses the source of the problem—not just its symptoms.

Immunotherapy desensitizes the body to allergens in the environment so that it will stop overreacting to them in ways that lead to troubling symptoms—including asthma.

Immunotherapy may be administered through injections or sublingually (as under-the-tongue drops that absorb into the bloodstream).  Sublingual immunotherapy (SLIT) is safer than shots and more convenient because it can be administered in the comfort of home rather than at the doctor’s office.

Contact AllergyEasy to learn about allergy drops for asthma or to find a sublingual immunotherapy clinic near you.

About The Author

Stuart H. Agren, M.D.

Stuart H. Agren, M.D. completed his undergraduate studies at the University of Utah and went on to earn his Doctor of Medicine from Tulane University School of Medicine in 1974. He completed additional training at L.D.S. Hospital in Salt Lake City, Utah and then established his private medical practice starting in 1975. Dr. Agren completed a mini-residency in Industrial Medicine at the Robert Johnson School of Medicine at Rutgers University and also completed training to become a certified Medical Review Officer.

Dr. Agren was the Medical Director at TRW and McDonnell Douglas in Mesa, Arizona and at Stauffer Chemical and Kennecott Copper in Salt Lake City, Utah. He also served as an adjunct faculty member at Arizona State University.

In his private medical practice, Dr. Agren specialized in family practice and allergy. In his work as a private practice allergist, he was one of the first doctors in the country to prescribe sublingual immunotherapy to his patients as an alternative to subcutaneous immunotherapy (allergy shots). He has also been a trailblazer in the field of food allergy treatment and research, developing a program to treat multiple food allergies simultaneously using sublingual immunotherapy. Dr. Agren has been featured on local CBS, NBC, and ABC news affiliates and won the peer-nominated “Top Doc” award from Phoenix Magazine.

After 20 years in private practice, Dr. Agren became the Founder and President of AllergyEasy, which helps primary care physicians around the country offer allergy testing and sublingual immunotherapy treatment to their patients. Over 200 physicians in over 32 states use the AllergyEasy program to help their patients overcome environmental and food allergies and asthma.